Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Pralsetinib in patients with RET fusion-positive non-small-cell lung cancer: A plain language summary of the ARROW study.
Journal: Future oncology (London, England)
Published: November 02, 2023
Exposure-Response Relationships for Pralsetinib in Patients with RET-Altered Thyroid Cancer or RET Fusion-Positive Nonsmall Cell Lung Cancer.
Journal: Journal of clinical pharmacology
Published: October 23, 2023
Quality of life with treated acute promyelocytic leukaemia.
Journal: The Lancet. Oncology
Published: January 21, 2015
Prediction model for heart failure in childhood cancer survivors.
Journal: The Lancet. Oncology
Published: January 21, 2015
Vemurafenib and cobimetinib in BRAF-mutated melanoma.
Journal: The Lancet. Oncology
Published: January 21, 2015
FOLFOXIRI and bevacizumab in metastatic colorectal cancer.
Journal: The Lancet. Oncology
Published: December 16, 2014
Type 2 diabetes and risk of pancreatic adenocarcinoma.
Journal: The Lancet. Oncology
Published: October 21, 2014
Sunitinib for atypical and anaplastic meningioma.
Journal: The Lancet. Oncology
Published: October 21, 2014
Showing 1-9 of 9
Last Updated: 09/26/2026